Small Lymphocytic Lymphoma — Trials

Small Lymphocytic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

479 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 129
Recruiting: 67
Ph III recruiting: 9
Growth YoY: −23.8%
Industry share: 37%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (108)

clinicaltrialsPublishedShowing 1–29 of 29 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05963074	A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia(TAILOR)	active not recruiting	Phase 2	333	Janssen Research & Development, LLCINDUSTRY	8	Sep 25, 2026	clinicaltrials
NCT02629809	Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia	active not recruiting	Phase 2	81	M.D. Anderson Cancer CenterOTHER	1